Latest filing published 13 Jan 2026 for LISATA THERAPEUTICS, INC..
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Steven M. Klosk: trading record in brief
Steven M. Klosk (board member) discloses dealings in 3 companies, chiefly Cambrex Corp, Lisata Therapeutics, Inc. and Bolt Projects Holdings, Inc. We count 189 filings; the first trade dates from 31 December 2005 and the latest from 9 January 2026.
On the open market, the record shows 13 purchases worth €102k and 96 sales worth €63.8M. Sales outweigh purchases by €63.7M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 33 share grants and 44 option exercises.
The median purchase comes to €1,814.
The record was last updated on 13 January 2026 with a share grant in Lisata Therapeutics, Inc. The clock since the last published purchase (25 November 2014) now reads 4,366 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Steven M. Klosk
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 30,456 shares0Common StockSEC:0001192621-26-000004:0
- 15,789 shares0Common StockSEC:0001192621-25-000002:0
- 15,000 shares0Common StockSEC:0001213900-24-103492:1
- 22,500 shares0Common StockSEC:0001213900-24-103492:0
- 35,000 sharesCommon StockSEC:0001213900-24-069731:0
- 19,480 shares0Common StockSEC:0001192621-24-000003:0
- 20,000 shares0Common StockSEC:0001192621-23-000002:0
- 65,430 shares0Common StockSEC:0001192621-22-000002:0
- 37,735 shares0Common StockSEC:0001192621-21-000003:0
- 18,292 shares@ US$3.2850.8% of flowRestricted Stock UnitsSEC:0001192621-20-000002:0
- 65,500 shares0Common StockSEC:0001209191-19-059247:4
- 50,000 shares@ US$41.364.3% of flowCommon StockSEC:0001209191-19-059247:0
- 50,000 shares@ US$40.654.2% of flowCommon StockSEC:0001209191-19-059247:1
- 38,000 shares@ US$45.643.6% of flowCommon StockSEC:0001209191-19-059247:2
- 30,000 shares@ US$53.613.4% of flowCommon StockSEC:0001209191-19-059247:3
- 347,206 shares@ US$60.0043.5% of flowCommon StockSEC:0001209191-19-059247:5
- 20,000 shares0Common StockSEC:0001209191-19-011177:0
- 10,378 shares0Common StockSEC:0001209191-19-007018:0
- 12,121 shares@ US$4.9549.2% of flowRestricted Stock UnitsSEC:0001192621-19-000013:0
- 8,747 shares0Common StockSEC:0001192621-19-000010:0
- 20,000 shares@ US$17.810.7% of flowCommon StockSEC:0001209191-18-056084:0
- 16,805 shares@ US$54.671.7% of flowCommon StockSEC:0001209191-18-056084:1
- 3,195 shares@ US$55.270.3% of flowCommon StockSEC:0001209191-18-056084:2
- 55,000 shares@ US$17.811.8% of flowCommon StockSEC:0001209191-18-049558:0
- 29,191 shares@ US$65.843.6% of flowCommon StockSEC:0001209191-18-049558:1
25 of 188 declarations
